These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19423528)

  • 1. Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast.
    Phillips LS; Millikan RC; Schroeder JC; Barnholtz-Sloan JS; Levine BJ
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1507-14. PubMed ID: 19423528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of reproductive risk factors for CIS lesions and invasive breast cancer.
    Wohlfahrt J; Rank F; Kroman N; Melbye M
    Int J Cancer; 2004 Feb; 108(5):750-3. PubMed ID: 14696102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses.
    Ruszczyk M; Zirpoli G; Kumar S; Bandera EV; Bovbjerg DH; Jandorf L; Khoury T; Hwang H; Ciupak G; Pawlish K; Schedin P; Masso-Welch P; Ambrosone CB; Hong CC
    Cancer Causes Control; 2016 Feb; 27(2):183-98. PubMed ID: 26621543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
    Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
    Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer.
    Kerlikowske K; Barclay J; Grady D; Sickles EA; Ernster V
    J Natl Cancer Inst; 1997 Jan; 89(1):76-82. PubMed ID: 8978410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54.
    Mayberry RM
    Ann Epidemiol; 1994 May; 4(3):205-13. PubMed ID: 8055121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast.
    Innos K; Horn-Ross PL
    Breast Cancer Res Treat; 2008 Oct; 111(3):531-40. PubMed ID: 17978879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial disparities in risk of second breast tumors after ductal carcinoma in situ.
    Liu Y; Colditz GA; Gehlert S; Goodman M
    Breast Cancer Res Treat; 2014 Nov; 148(1):163-73. PubMed ID: 25261293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast carcinoma in situ: risk factors and screening patterns.
    Claus EB; Stowe M; Carter D
    J Natl Cancer Inst; 2001 Dec; 93(23):1811-7. PubMed ID: 11734598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for estrogen receptor positive ductal carcinoma in situ of the breast in African American women.
    Bertrand KA; Bethea TN; Rosenberg L; Bandera EV; Khoury T; Troester MA; Ambrosone CB; Palmer JR
    Breast; 2020 Feb; 49():108-114. PubMed ID: 31786415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The need for epidemiologic studies of in-situ carcinoma of the breast.
    Millikan R; Dressler L; Geradts J; Graham M
    Breast Cancer Res Treat; 1995 Jul; 35(1):65-77. PubMed ID: 7612906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous expression of nm23 gene product in noninvasive breast carcinoma.
    Simpson JF; O'Malley F; Dupont WD; Page DL
    Cancer; 1994 May; 73(9):2352-8. PubMed ID: 7513249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
    Liu Y; West R; Weber JD; Colditz GA
    Cancer; 2019 Sep; 125(18):3225-3233. PubMed ID: 31120565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive and menstrual factors and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women.
    Kabat GC; Kim MY; Woods NF; Habel LA; Messina CR; Wactawski-Wende J; Stefanick ML; Chlebowski RT; Wassertheil-Smoller S; Rohan TE
    Cancer Causes Control; 2011 Oct; 22(10):1415-24. PubMed ID: 21750889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of care analysis among women with ductal carcinoma in situ in North Carolina.
    Jackson LC; Camacho F; Levine EA; Anderson RT; Stewart JH
    Am J Surg; 2008 Feb; 195(2):164-9. PubMed ID: 18096124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammographic pattern of microcalcifications in the preoperative diagnosis of comedo ductal carcinoma in situ: histopathologic correlation.
    Hermann G; Keller RJ; Drossman S; Caravella BA; Tartter P; Panetta RA; Bleiweiss IJ
    Can Assoc Radiol J; 1999 Aug; 50(4):235-40. PubMed ID: 10459309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol intake and invasive breast cancer risk by molecular subtype and race in the Carolina Breast Cancer Study.
    Williams LA; Olshan AF; Tse CK; Bell ME; Troester MA
    Cancer Causes Control; 2016 Feb; 27(2):259-69. PubMed ID: 26705260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of amplified int-2/FGF-3 gene in primary breast carcinomas using differential polymerase chain reaction.
    Naidu R; Wahab NA; Yadav M; Kutty MK; Nair S
    Int J Mol Med; 2001 Aug; 8(2):193-8. PubMed ID: 11445874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent trends and racial/ethnic differences in the incidence and treatment of ductal carcinoma in situ of the breast in California women.
    Innos K; Horn-Ross PL
    Cancer; 2003 Feb; 97(4):1099-106. PubMed ID: 12569612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of recurrence after ductal carcinoma in situ of the breast.
    Habel LA; Daling JR; Newcomb PA; Self SG; Porter PL; Stanford JL; Seidel K; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):689-96. PubMed ID: 9718221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.